New study finds presence of regulatory T cells enables partial recovery from paralysis

New study finds presence of regulatory T cells enables partial recovery from paralysis
Regulatory T cells (green) shown interacting with pathogenic Th17 cells (red) near collagen fibers (blue) in the spinal cord in a model of multiple sclerosis. Credit: UCI School of Medicine

In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).

Published in the Proceedings of the National Academy of Sciences, the results of the study help explain how Treg cells prevent autoimmunity and dampen immune responses, specifically the negative effects of type 17 helper T cells (Th17) which are known to drive the progression of several autoimmune diseases.

This new study, which builds on recent research that identified pathogenic Th17 cells and their role in the progression of several autoimmune diseases, showed how the inhibition of Th17 cells by Treg cells enabled partial recovery from paralysis. This finding demonstrates how autoimmune diseases may be effectively targeted using Treg-based cellular therapies.

"We discovered a unique 'repetitive scanning motility' by which Treg cells (the good guys) dampen calcium signaling in pathogenic Th17 cells (the bad guys), and help to resolve neuroinflammation and limit reactivation of Th17 cells in the ," explained Shivashankar Othy, Ph.D., lead author of the study with Amit Jairaman, Ph.D., both project scientists in the Cahalan Lab at UCI.

Senior author, Michael D. Cahalan, Ph.D., distinguished professor and chair of the Department of Physiology & Biophysics at the UCI School of Medicine, added, "Building on our years of expertise in immunoimaging and calcium signaling, this study highlights Th17 and Treg cell interactions, their motility characteristics, and intracellular signaling, thus providing new insights into the pathophysiology of MS. Our results illustrate how a regulatory T cell-based immunotherapy may be instrumental in limiting demyelination in MS."

Explore further

Cellular metabolism regulates the fate decision between pathogenic and regulatory T cells

More information: Shivashankar Othy et al, Regulatory T cells suppress Th17 cell Ca2+signaling in the spinal cord during murine autoimmune neuroinflammation, Proceedings of the National Academy of Sciences (2020). DOI: 10.1073/pnas.2006895117
Citation: New study finds presence of regulatory T cells enables partial recovery from paralysis (2020, September 21) retrieved 28 June 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors